Ezetimibe Tablet
Product Images NDC 71335-3092

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 71335-3092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Camber-logo2 (Camber Logo2)

FDA Label Image

Ezetimibetabletstructure (Ezetimibetabletstructure)

Ezetimibetabletstructure (Ezetimibetabletstructure)
Chemical structure diagram of the active ingredient ezetimibe, showing its molecular framework including hydroxyl groups, aromatic rings, fluorine, nitrogen, and oxygen atoms arranged in the characteristic configuration.*
FDA Label Image

Label (Lbl713353092)

Label (Lbl713353092)
Label for Ezetimibe Tablets, USP 10 mg oral tablets, repackaged by Bryant Ranch Prepack and manufactured by Hetero Labs Limited. The package contains 30 tablets. The label includes storage instructions, warnings to keep out of reach of children, and QR codes for packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.